Skip to main content
Clinical Trials/CTRI/2023/08/056234
CTRI/2023/08/056234
Not Yet Recruiting
Phase 4

A Clinical Study to Evaluate the Safety and Efficacy of Panchakarma Essential in female patients with generalized anxiety disorder - NI

Mprex Healthcare Pvt. Ltd.0 sites0 target enrollmentTBD

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Not specified
Sponsor
Mprex Healthcare Pvt. Ltd.
Status
Not Yet Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Eligibility Criteria

Inclusion Criteria

  • 1\.Female subjects 30\-60 years of age will be included.2\.Female subjects with no history of allergy to oils.3\.Be willing to refrain from taking any medication during or before the study for the said indication.
  • 4\.An ambulatory female subject can provide verbal and written consent and is ready to comply with all study procedures.

Exclusion Criteria

  • 1\. Female subjects with Depression, Social phobias, Hypertension, Cardiac diseases, Epilepsy, Asthma, Hyperthyroidism, Alcoholics, and Drug addicts
  • 2\. History of psychiatric disorder that may impair the ability of subjects to provide written informed consent.

Outcomes

Primary Outcomes

Not specified

Similar Trials